Display options
Cite
Devapatla B, Shidal C, Yaddanapudi K, et al. Validation of syngeneic mouse models of melanoma and non-small cell lung cancer for investigating the anticancer effects of the soy-derived peptide Lunasin. F1000Res. 2016;5:2432doi: 10.12688/f1000research.9661.2.
Devapatla, B., Shidal, C., Yaddanapudi, K., & Davis, K. R. (2016). Validation of syngeneic mouse models of melanoma and non-small cell lung cancer for investigating the anticancer effects of the soy-derived peptide Lunasin. F1000Research, 52432. https://doi.org/10.12688/f1000research.9661.2
Devapatla, Bharat, et al. "Validation of syngeneic mouse models of melanoma and non-small cell lung cancer for investigating the anticancer effects of the soy-derived peptide Lunasin." F1000Research vol. 5 (2016): 2432. doi: https://doi.org/10.12688/f1000research.9661.2
Devapatla B, Shidal C, Yaddanapudi K, Davis KR. Validation of syngeneic mouse models of melanoma and non-small cell lung cancer for investigating the anticancer effects of the soy-derived peptide Lunasin. F1000Res. 2016 Oct 04;5:2432. doi: 10.12688/f1000research.9661.2. eCollection 2016. PMID: 28299174; PMCID: PMC5325107.
Copy Download .nbib Format: NLM
Share it on

F1000Res. 2016 Oct 04;5:2432. doi: 10.12688/f1000research.9661.2. eCollection 2016.

Validation of syngeneic mouse models of melanoma and non-small cell lung cancer for investigating the anticancer effects of the soy-derived peptide Lunasin.

F1000Research

Bharat Devapatla, Chris Shidal, Kavitha Yaddanapudi, Keith R Davis

Affiliations

  1. Department of Pharmacology and Toxicology, University of Louisville School of Medicine, , Louisville, KY, 40402, USA.
  2. Department of Pharmacology and Toxicology, University of Louisville School of Medicine, , Louisville, KY, 40402, USA; Department of Biology and Biotechnology Program, Indiana University, Bloomington, IN, 47405, USA.
  3. Department of Medicine and James Graham Brown Cancer Center, University of Louisville School of Medicine, Louisville, KY, 40402, USA.
  4. Department of Biology and Biotechnology Program, Indiana University, Bloomington, IN, 47405, USA.

PMID: 28299174 PMCID: PMC5325107 DOI: 10.12688/f1000research.9661.2

[No abstract available.]

Keywords: B16-F0; LLC; Lung cancer; Melanoma; Syngeneic tumor model

Conflict of interest statement

Competing interests: KRD is listed as an inventor on two issued patents relating to the expression and purification of Lunasin peptides and may benefit financially if the technologies described in the

References

  1. Mol Nutr Food Res. 2011 Jul;55(7):989-98 - PubMed
  2. Nutr Cancer. 2003;47(1):88-94 - PubMed
  3. Vaccine. 2014 Sep 22;32(42):5411-9 - PubMed
  4. PLoS One. 2010 Jan 26;5(1):e8890 - PubMed
  5. Mol Nutr Food Res. 2012 Oct;56(10):1569-81 - PubMed
  6. Oncotarget. 2015 Mar 10;6(7):4649-62 - PubMed
  7. Genes Nutr. 2015 Nov;10(6):49 - PubMed
  8. Chem Biol Interact. 2010 Jul 30;186(2):127-34 - PubMed
  9. Cancer Res. 2001 Oct 15;61(20):7473-8 - PubMed
  10. F1000Res. 2016 Oct 4;5:2432 - PubMed
  11. Eur Rev Med Pharmacol Sci. 2014;18(14):2070-5 - PubMed
  12. Plant Foods Hum Nutr. 2011 Jun;66(2):107-13 - PubMed
  13. Oncotarget. 2016 Dec 20;7(51):84128-84141 - PubMed
  14. J Food Sci. 2015 Mar;80(3):R485-94 - PubMed
  15. Cancer Immunol Immunother. 2014 Mar;63(3):283-95 - PubMed
  16. Neuro Oncol. 2015 May;17(5):708-17 - PubMed
  17. Neuro Oncol. 2015 Oct;17(10):1386-92 - PubMed
  18. J Food Sci. 2012 May;77(5):C539-45 - PubMed
  19. Cancer Lett. 2011 Dec 27;313(2):167-80 - PubMed
  20. Cancer Lett. 2010 Sep 1;295(1):44-53 - PubMed
  21. Oncotarget. 2017 Apr 11;8(15):25525-25541 - PubMed
  22. J Agric Food Chem. 2009 Feb 25;57(4):1260-6 - PubMed
  23. Protein Pept Lett. 2013 Apr;20(4):424-32 - PubMed
  24. J Agric Food Chem. 2007 Feb 7;55(3):632-7 - PubMed
  25. PLoS One. 2015 Feb 03;10(2):e0115330 - PubMed
  26. Oncol Rep. 2016 Jul;36(1):253-62 - PubMed
  27. PLoS One. 2012;7(4):e35409 - PubMed
  28. Int J Mol Sci. 2014 Dec 18;15(12):23705-24 - PubMed

Publication Types